Dicerna Pharmaceutic
(DRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 165,756 | 221,210 | 159,111 | 126,767 | 204,281 |
| Marketable Securities | 399,753 | 371,755 | 385,773 | 442,820 | 405,632 |
| Receivables | 6,226 | 3,147 | 31,267 | 34,713 | 5,028 |
| TOTAL | $589,003 | $616,492 | $594,500 | $618,703 | $627,651 |
| Non-Current Assets | |||||
| PPE Net | 22,096 | 23,593 | 18,873 | 17,546 | 12,846 |
| Investments And Advances | 81,084 | 116,599 | 0 | 0 | 0 |
| Other Non-Current Assets | 79,876 | 81,808 | 70,037 | 71,597 | 41,241 |
| TOTAL | $183,056 | $222,000 | $88,910 | $89,143 | $54,087 |
| Total Assets | $772,059 | $838,492 | $683,410 | $707,846 | $681,738 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,320 | 12,829 | 11,276 | 7,901 | 7,249 |
| Accrued Expenses | 34,125 | 29,577 | 28,850 | 28,061 | 30,050 |
| TOTAL | $239,295 | $207,650 | $182,147 | $177,938 | $239,768 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 190,128 | 160,200 | 137,954 | 138,537 | 200,041 |
| Other Non-Current Liabilities | 66,509 | 72,454 | 56,541 | 55,918 | 19,768 |
| TOTAL | $425,101 | $519,768 | $374,859 | $392,154 | $288,270 |
| Total Liabilities | $664,396 | $727,418 | $557,006 | $570,092 | $528,038 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,889 | 77,734 | 76,900 | 76,321 | 75,045 |
| Common Shares | 8 | 8 | 8 | 8 | 7 |
| Retained earnings | -725,915 | -708,843 | -668,028 | -638,063 | -601,477 |
| TOTAL | $107,663 | $111,074 | $126,404 | $137,754 | $153,700 |
| Total Liabilities And Equity | $772,059 | $838,492 | $683,410 | $707,846 | $681,738 |